Inhibition of calcineurin by the tyrphostin class of tyrosine kinase inhibitors

Biochemical Pharmacology

Volumn 56, Issue 4, 1998, Pages 483-488

  Martin, Bruce L ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Calcineurin; Calmodulin activated phosphatase; Dual specificity phosphatase; Tyrosine kinase inhibitors; Tyrphostins

Indexed keywords

CALCINEURIN; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN;

ANIMAL TISSUE; ARTICLE; BRAIN; CATTLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

CALCINEURIN; CATECHOLS; ENZYME INHIBITORS; NITRILES; PROTEIN-TYROSINE KINASES; STRUCTURE-ACTIVITY RELATIONSHIP; TYRPHOSTINS;

EID: 0031781898     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00181-6     Document Type: Article

References (42)

1. Pinna L.A., Ruzzene M. How do protein kinases recognize their substrates? Biochim Biophys Acta. 1314:1996;191-225.
2. Pinna L.A., Donella-Deana A. Phosphorylated synthetic peptides as tools for studying protein phosphatases. Biochim Biophys Acta. 1222:1994;415-431.
3. Barford D., Flint A.J., Tonks N.K. Crystal structure of human protein tyrosine phosphatase 1B. Science. 263:1994;1397-1404.
4. Jia Z., Barford D., Flint A.J., Tonks N.K. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science. 268:1995;1754-1758.
5. Stuckey J.A., Schubert H.L., Fauman E.B., Zhang Z.-Y., Dixon J.E., Saper M.A. Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate. Nature. 370:1994;571-575.
6. Schubert H.L., Fauman E.B., Stuckey J.A., Dixon J.E., Saper M.A. A ligand-induced conformational change in the Yersinia protein tyrosine phosphatase. Protein Sci. 4:1995;1904-1913.
7. Griffith J.P., Kim J.L., Kim E.E., Sintchak M.D., Thomson J.A., Fitzgibbon M.J., Fleming M.A., Caron P.R., Hsiao K., Navia M.A. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell. 82:1995;507-522.
8. Kissinger C.R., Parge H.E., Knighton D.R., Lewis C.T., Pelletier L.A., Tempczyk A., Kalish V.J., Tucker K.D., Showalter R.E., Moomaw E.W., Gastinel L.N., Habuka N., Chen X., Maldonado F., Barker J.E., Bacquet R., Villafranca J.E. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature. 378:1995;641-644.
9. Goldberg J., Huang H-b, Kwon Y, Greengard P., Nairn A.C., Kuriyan J. Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1. Nature. 376:1995;745-753.
10. Egloff M.-P., Cohen P.T.W., Reinemer P., Barford D. Crystal structure of the catalytic subunit of human protein phosphatase 1 and its complex with tungstate. J Mol Biol. 254:1995;942-959.
11. Cohen P.T.W., Brewis N.D., Hughes V., Mann D.J. Protein serine/threonine phosphatases An expanding family . FEBS Lett. 268:1990;355-359.
12. Pallen C.J., Wang J.H. Calmodulin-stimulated dephosphorylation of p-nitrophenyl phosphate and free phosphotyrosine by calcineurin. J Biol Chem. 258:1983;8550-8553.
13. Pallen C.J., Brown M.L., Matsui H., Mitchell K.J., Wang J.H. Survey of calcineurin activity towards nonprotein compounds and identification of phosphoenol pyruvate as a substrate. Biochem Biophys Res Commun. 131:1985;1256-1261.
14. Martin B.L., Pallen C.J., Wang J.H., Graves D.J. Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphatase activity of calcineurin. J Biol Chem. 260:1985;14932-14937.
15. Chan C.P., Gallis B., Blumenthal D.K., Pallen C.J., Wang J.H., Krebs E.G. Characterization of the phosphotyrosyl protein phosphatase activity of calmodulin-dependent protein phosphatase. J Biol Chem. 261:1986;9890-9895.
16. Blumenthal D.K., Takio K., Hansen R.S., Krebs E.G. Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (type II) by calmodulin-dependent protein phosphatase. Determinants of substrate specificity. J Biol Chem. 261:1986;8140-8145.
17. King M.M., Huang C.Y., Chock P.B., Nairn A.C., Hemmings H.C., Chan K.F.J., Greengard P. Mammalian brain phosphoproteins as substrates for calcineurin. J Biol Chem. 259:1984;8080-8083.
18. Pallen C.J., Valentine K.A., Wang J.H., Hollenberg M.D. Calcineurin-mediated dephosphorylation of the human placental membrane receptor for epidermal growth factor urogastrone. Biochemistry. 24:1985;4727-4730.
19. Yaish P., Gazit A., Gilon C., Levitzki A. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science. 242:1988;933-935.
20. Levitzki A., Gazit A. Tyrosine kinase inhibition An approach to drug development . Science. 267:1995;1782-1788.
21. Sharma R.K., Taylor W.A., Wang J.H. Use of calmodulin affinity chromatography for purification of specific calmodulin-dependent enzymes. Methods Enzymol. 102:1983;210-219.
22. 2+-dependent modulator protein. Adv Cyclic Nucleotide Res. 10:1979;187-198.
23. 2+-induced hydrophobic site on calmodulin Application for purification of calmodulin by phenyl-Sepharose affinity chromatography . Biochem Biophys Res Commun. 104:1982;830-836.
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
25. Donella-Deana A., Krinks M.H., Ruzzene M., Klee C., Pinna L.A. Dephosphorylation of phosphopeptides by calcineurin (protein phosphatase 2B). Eur J Biochem. 219:1994;109-117.
26. King M.M., Huang C.Y. Activation of calcineurin by nickel ions. Biochem Biophys Res Commun. 114:1983;955-961.
27. King M.M., Huang C.Y. The calmodulin-dependent activation and deactivation of the phosphoprotein phosphatase, calcineurin, and the effect of nucleotides, pyrophosphate, and divalent metal ions. Identification of calcineurin as a Zn and Fe metalloenzyme. J Biol Chem. 259:1984;8847-8856.
28. Pallen C.J., Wang J.H. Regulation of calcineurin by metal ions. J Biol Chem. 259:1984;6134-6141.
29. 2+. J Biol Chem. 259:1984;8801-8807.
30. Wolff D.J., Sved D.W. The divalent cation dependence of bovine brain calmodulin-dependent phosphatase. J Biol Chem. 260:1985;4195-4202.
31. Spessard GO and Miessler GL, Organometallic Chemistry, Chapters 4 and 5. Prentice-Hall, Upper Saddle River, NJ, 1997.
32. Martin B.L., Graves D.J. Mechanistic aspects of the low molecular weight phosphatase activity of the calmodulin-activated phosphatase, calcineurin. J Biol Chem. 261:1986;14545-14550.
33. Born T.L., Myers J.K., Widlanski T.S., Rusnak F. 4-(Fluoromethyl)phenyl phosphate acts as a mechanism-based inhibitor of calcineurin. J Biol Chem. 270:1995;25651-25655.
34. Liu J., Albers M.W., Wandless T.J., Luan S., Alberg D.G., Belshaw P.J., Cohen P., MacKintosh C., Klee C.B., Schreiber S.L. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry. 31:1992;3896-3901.
35. Swanson S.K.H., Born T., Zydowsky L.D., Cho H., Chang H.Y., Walsh C.T., Rusnak F. Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. Proc Natl Acad Sci USA. 89:1992;3741-3745.
36. Enan E., Matsumura F. Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides. Biochem Pharmacol. 43:1992;1777-1784.
37. Enz A., Pombo-Villar E. Class II pyrethroids Noninhibitors of calcineurin . Biochem Pharmacol. 54:1997;321-323.
38. Wolbring G., Hollenberg M.D., Schnetkamp P.P.M. Inhibition of GTP-utilizing enzymes by tyrphostins. J Biol Chem. 269:1994;22470-22472.
39. Aflalo E., Iftach S., Segal S., Gazit A., Priel E. Inhibition of topoisomerase I activity by tyrphostin derivatives, protein tyrosine kinase blockers Mechanism of action . Cancer Res. 54:1994;5138-5142.
40. Ben-Hassat H., Vardi D.V., Gazit A., Klaus S.N., Chaouat M., Hartzstark Z., Levitzki A. Tyrphostins suppress the growth of psoriatic keratinocytes. Exp Dermatol. 4:1995;82-88.
41. Berth-Jones J., Henderson C.A., Munro C.S., Chalmers R.J.G., Boffa M.J., Norris P.G., Friedmann P.S., Graham-Brown R.A.C., Dowd P.M., Marks R., Sumner M.J. Treatment of psoriasis with intermittent short course cyclosporin (Neoral). Br J Dermatol. 136:1997;527-530.
42. Mahrle G., Schulze H.J., Brautigam M., Mischer P., Schopf R., Jung E.G., Weidinger G., Farber L. Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis A prospective multicentre study . Br J Dermatol. 135:1996;752-757.